☆ 4.7 Article

Pan-HDAC inhibitors augment IL2-induced proliferation of NK cells via the JAK2-STAT5B signaling pathway

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell & Tissue Engineering

SAHA Enhances Differentiation of CD34+CD45+Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium

Seon-Hui Shim et al.

Summary: Epigenetic modification plays an important role in hematopoietic cell differentiation. This study demonstrates that histone deacetylase inhibitors can enhance the differentiation of pluripotent stem cells into hematopoietic stem and progenitor cells, overcoming a major bottleneck in cellular immunotherapy.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Augmentation of NK Cell Proliferation and Anti-tumor Immunity by Transgenic Expression of Receptors for EPO or TPO

Chantiya Chanswangphuwana et al.

Summary: The research demonstrated that genetic engineering of NK cells to express EPO receptor or TPO receptor can enhance cell survival and function, and increase cytotoxicity. The results showed that c-MPL receptor expression could improve NK cell proliferation and cytokine production, potentially enhancing NK cell antitumor immunity.

MOLECULAR THERAPY (2021)

添加到收藏夹

Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Hypoxia-Driven HIF-1α Activation Reprograms Pre-Activated NK Cells towards Highly Potent Effector Phenotypes via ERK/STAT3 Pathways

Seon Ah Lim et al.

Summary: In patients with advanced cancer, hypoxic stress shapes NK cells towards tumor-resistant and immunosuppressive phenotypes. Restoring NK cell function within hypoxia is crucial for successful tumor immunotherapy. Manipulating pO(2) exposure to naive vs. pre-activated NK cells, HIF-1 alpha-dependent metabolic reprogramming proved key to overcoming hypoxia-induced NK cell impairment, generating functionally robust NK cells for adoptive therapy and clinical evaluation.

CANCERS (2021)

添加到收藏夹

Article Immunology

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

Hemant K. Mishra et al.

Summary: Natural killer (NK) cells play a crucial role in tumor treatment, but face challenges in persistence and function. Research shows that blocking ADAM17 can increase NK cell proliferation in vivo, increase CD62L levels on the cell surface, and enhance the process dependent on CD62L.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat

Lukman O. Afolabi et al.

Summary: The pan-HDAC inhibitor panobinostat demonstrated anti-tumor and anti-proliferative activities on various tumors in vitro and when combined with NK cells, showed synergistic effects in mediating tumor cell cytolysis. Mechanistically, panobinostat treatment increased expression of cell adhesion and tight junction-related genes, promoted conjugation formation between NK and tumor cells, and modulated NK cell-activating receptors and ligands on tumor cells, contributing to enhanced tumor cytolysis. Overall, panobinostat therapy exhibited better tumor control and synergized with anti-PD-L1 therapy, highlighting its potential in enhancing NK cell-based immunotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

CAR-NK for tumor immunotherapy: Clinical transformation and future prospects

Wenxiu Wang et al.

CANCER LETTERS (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Boosting Natural Killer Cell-Based Cancer Immunotherapy with Selenocystine/Transforming Growth Factor-Beta Inhibitor-Encapsulated Nanoemulsion

Chang Liu et al.

ACS NANO (2020)

添加到收藏夹

Review Immunology

Molecular Regulation of NK Cell Maturation

Jiacheng Bi et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC

Viviane Ponath et al.

CANCERS (2020)

添加到收藏夹

Review Immunology

Human NK Cell Development: One Road or Many?

Frank Cichocki et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV plus individuals

Carolina Garrido et al.

AIDS (2019)

添加到收藏夹

Review Immunology

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation

Dagmar Gotthardt et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Oncogene-induced senescence: a double edged sword in cancer

Xue-ling Liu et al.

ACTA PHARMACOLOGICA SINICA (2018)

添加到收藏夹

Review Immunology

STATs in NK-Cells: The Good, the Bad, and the Ugly

Dagmar Gotthardt et al.

FRONTIERS IN IMMUNOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3

Lulu Ni et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Oncology

Selection and expansion of natural killer cells for NK cell-based immunotherapy

Petra S. A. Becker et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)

添加到收藏夹

Article Medicine, Research & Experimental

HDACs and HDAC Inhibitors in Cancer Development and Therapy

Yixuan Li et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

添加到收藏夹

Review Immunology

Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells

Hans Klingemann et al.

FRONTIERS IN IMMUNOLOGY (2016)

添加到收藏夹

Article Immunology

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function

Carolina Garrido et al.

FRONTIERS IN IMMUNOLOGY (2016)

添加到收藏夹

Article Cell Biology

Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors

Jaydeep Bhat et al.

CELLULAR IMMUNOLOGY (2015)

添加到收藏夹

Article Immunology

Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B

Inna S. Afonina et al.

IMMUNOLOGICAL REVIEWS (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Epigenetic reprogramming induces the expansion of cord blood stem cells

Pratima Chaurasia et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

添加到收藏夹

Review Immunology

Development of human natural killer cells and other innate lymphoid cells

Elisa Montaldo et al.

SEMINARS IN IMMUNOLOGY (2014)

添加到收藏夹

Review Immunology

Human natural killer cell development in secondary lymphoid tissues

Aharon G. Freud et al.

SEMINARS IN IMMUNOLOGY (2014)

添加到收藏夹

Letter Oncology

Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

Y. Oki et al.

BLOOD CANCER JOURNAL (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages

Melanie R. Shakespear et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

添加到收藏夹

Review Immunology

Targeting natural killer cells and natural killer T cells in cancer

Eric Vivier et al.

NATURE REVIEWS IMMUNOLOGY (2012)

添加到收藏夹

Review Immunology

Histone deacetylases as regulators of inflammation and immunity

Melanie R. Shakespear et al.

TRENDS IN IMMUNOLOGY (2011)

添加到收藏夹

Review Immunology

Up on the tightrope: natural killer cell activation and inhibition

Lewis L. Lanier

NATURE IMMUNOLOGY (2008)

添加到收藏夹

Review Oncology

Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?

T. C. Karagiannis et al.

LEUKEMIA (2007)

添加到收藏夹

Review Immunology

Tolerance, not immunity, crucially depends on IL-2

TR Malek et al.

NATURE REVIEWS IMMUNOLOGY (2004)

添加到收藏夹

Review Immunology

Functional significance of the perforin/granzyme cell death pathway

JA Trapani et al.

NATURE REVIEWS IMMUNOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.